We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.71B
AUM Growth
-$59.4M
Cap. Flow
-$79.2M
Cap. Flow %
-4.64%
Top 10 Hldgs %
33.42%
Holding
2,129
New
759
Increased
317
Reduced
327
Closed
710

Sector Composition

Rank Sector Weight
1 Financials 11.1%
2 Technology 9.71%
3 Consumer Discretionary 4.04%
4 Healthcare 3.83%
5 Industrials 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMBI
1376
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$14K ﹤0.01%
3,294
-1,208
-27% -$5.27K
IZEA icon
1377
IZEA Worldwide
IZEA
$62.5M
$13K ﹤0.01%
6,546
+3,630
+124% +$11.1K
FELP
1378
DELISTED
Foresight Energy LP
FELP
$13K ﹤0.01%
+18,024
New +$21.4K
CBAT icon
1379
CBAK Energy Technology Ltd
CBAT
$69.2M
$12K ﹤0.01%
12,375
-69,648
-85% -$67.9K
AMPE
1380
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$12K ﹤0.01%
106
+41
+63% +$6.5K
AEMD icon
1381
Aethlon Medical
AEMD
$1.67M
0
GMO
1382
DELISTED
General Moly, Inc.
GMO
$11K ﹤0.01%
31,108
-32,955
-51% -$9.46K
SCON
1383
DELISTED
Superconductor Technologies Inc.
SCON
$11K ﹤0.01%
1,321
+240
+22% +$2.95K
AGIG
1384
Abundia Global Impact Group
AGIG
$39.2M
$10K ﹤0.01%
+379
New +$11.3K
CPHI icon
1385
China Pharma Holdings
CPHI
$45.8M
$9K ﹤0.01%
+58
New +$9.31K
CREG
1386
DELISTED
Smart Powerr
CREG
$9K ﹤0.01%
20
+5
+33% +$3K
PLX icon
1387
Protalix BioTherapeutics
PLX
$196M
$9K ﹤0.01%
1,948
-5,869
-75% -$24.8K
QCLS
1388
Q/C Technologies Inc
QCLS
$22.7M
0
BLPH
1389
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$9K ﹤0.01%
1,005
-94
-9% -$901
JASN
1390
DELISTED
Jason Industries, Inc.
JASN
$9K ﹤0.01%
+14,552
New +$17.2K
CTIC
1391
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$9K ﹤0.01%
+10,533
New +$9.72K
IBIO icon
1392
iBio
IBIO
$73M
$8K ﹤0.01%
22
-13
-37% -$5.25K
LODE icon
1393
Comstock
LODE
$270M
$8K ﹤0.01%
823
-1,072
-57% -$11.1K
GNMX
1394
DELISTED
Aevi Genomic Medicine Inc
GNMX
$8K ﹤0.01%
47,137
-231,821
-83% -$46.9K
ARCW
1395
DELISTED
ARC Group Worldwide, Inc
ARCW
$8K ﹤0.01%
+16,744
New +$10.8K
HK
1396
DELISTED
Halcon Resources Corporation
HK
$8K ﹤0.01%
+46,515
New +$33.9K
PRSO icon
1397
Peraso
PRSO
$10.8M
$7K ﹤0.01%
49
+11
+29% +$1.78K
AAU
1398
DELISTED
Almaden Minerals Ltd
AAU
$7K ﹤0.01%
+11,693
New +$6.11K
SQBG
1399
DELISTED
Sequential Brands Group, Inc.
SQBG
$7K ﹤0.01%
+309
New +$10.4K
TRNX
1400
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$7K ﹤0.01%
9,289
-22,875
-71% -$57.7K

Similar funds

Virtu Financial's Q2 2019 Portfolio in Review

As of Q2 2019, Virtu Financial held 2,129 positions worth $1.71B, down 3.4% from $1.77B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Virtu Financial withdrew a net $79.2M in Q2 2019, closing 710 positions and reducing 327 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $21.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 4.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Virtu Financial opened a new position in L3 Technologies, Inc. worth $41.1M.

  • Virtu Financial's largest Q2 2019 buy was L3 Technologies, Inc.: 167,812 shares worth $41.1M.
  • Virtu Financial added most to Berkshire Hathaway Class A in Q2 2019, an estimated $76.8M increase.
  • Virtu Financial's biggest Q2 2019 reduction was SPDR Gold Trust, cutting an estimated $76.6M.
  • Virtu Financial fully exited iShares Russell 2000 ETF in Q2 2019, selling an estimated $21.7M.
  • Virtu Financial's ten largest holdings make up 33% of its $1.71B portfolio in Q2 2019.
  • Virtu Financial opened 759 new positions and closed 710 in Q2 2019.
  • Virtu Financial's portfolio value fell 3.4% quarter-over-quarter to $1.71B.

Based on Virtu Financial's 13F filing for Q2 2019, filed 13 Aug 2019.